Nevanac 1 mg / ml, Augentropfensuspension

7680587450011 CH-58745 Augentropfensuspension
Nevanac 1 mg / ml, Augentropfensuspension
Nevanac 1 mg / ml, Augentropfensuspension
Nevanac 1 mg / ml, Augentropfensuspension
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Flasche(n)
Galenic form
Augentropfensuspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/03/2025
Patient information leaflet
Français
29/03/2025
Patient information leaflet
Italien
29/03/2025
Summary of Product Characteristics
Allemand
29/03/2025
Summary of Product Characteristics
Français
29/03/2025
Summary of Product Characteristics
Italien
29/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 UG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 30.25
Specialties list
Yes
Generic
No
SL addition date: 01/02/2009

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
58745
Drug name
Nevanac 1 mg / ml, Augentropfensuspension
Galenic form
AUGN
ATC Code
S01BC10
Authorization status
Z
Dispensing category
B
First authorization
24/09/2008
Authorization expiration date
31/12/9999
IT Number
11.06.3.
Domain
Human medicine
Field of application
Nicht-steroidaler Entzündungshemmer zur Applikation am Auge

Package details

Description (FR)
NEVANAC susp opht 0.1 % fl 5 ml
Description (DE)
NEVANAC Susp Opht 0.1 % Fl 5 ml
Market launch
24/09/2008
Narcotic (BTM)
No